- Home
- BCAT vs AZTA Comparison
BCAT vs AZTA Comparison
Compare BCAT & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAT
- AZTA
- Stock Information
- Founded
- BCAT 2020
- AZTA 1978
- Country
- BCAT United States
- AZTA United States
- Employees
- BCAT N/A
- AZTA N/A
- Industry
- BCAT Finance/Investors Services
- AZTA Industrial Machinery/Components
- Sector
- BCAT Finance
- AZTA Technology
- Exchange
- BCAT Nasdaq
- AZTA Nasdaq
- Market Cap
- BCAT 1.5B
- AZTA 1.4B
- IPO Year
- BCAT N/A
- AZTA 1995
- Fundamental
- Price
- BCAT $14.93
- AZTA $28.27
- Analyst Decision
- BCAT
- AZTA Buy
- Analyst Count
- BCAT 0
- AZTA 3
- Target Price
- BCAT N/A
- AZTA $44.33
- AVG Volume (30 Days)
- BCAT 308.8K
- AZTA 609.2K
- Earning Date
- BCAT 01-01-0001
- AZTA 08-05-2025
- Dividend Yield
- BCAT 9.38%
- AZTA N/A
- EPS Growth
- BCAT N/A
- AZTA N/A
- EPS
- BCAT 1.43
- AZTA N/A
- Revenue
- BCAT N/A
- AZTA $668,821,000.00
- Revenue This Year
- BCAT N/A
- AZTA N/A
- Revenue Next Year
- BCAT N/A
- AZTA $4.74
- P/E Ratio
- BCAT $11.41
- AZTA N/A
- Revenue Growth
- BCAT N/A
- AZTA 7.31
- 52 Week Low
- BCAT $13.67
- AZTA $23.91
- 52 Week High
- BCAT $16.38
- AZTA $60.60
- Technical
- Relative Strength Index (RSI)
- BCAT 50.38
- AZTA 41.85
- Support Level
- BCAT $14.71
- AZTA $26.46
- Resistance Level
- BCAT $14.98
- AZTA $32.65
- Average True Range (ATR)
- BCAT 0.13
- AZTA 1.82
- MACD
- BCAT -0.00
- AZTA -0.63
- Stochastic Oscillator
- BCAT 75.59
- AZTA 34.95
About BCAT BlackRock Capital Allocation Term Trust of Beneficial Interest
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.